Peter Barrett

Director, Revvity Inc.

Companies

Obsidian Therapeutics, Inc.Board member Aug 3, 2026 to now¹
Revvity Inc.Board member Feb 6, 2012 to now²
SYNLOGIC, INC.Board member Aug 30, 2017 to Jan 4, 2024³
Zafgen (United States)Board member Jun 18, 2014 to May 12, 2022⁴
SciClone Pharmaceuticals (United States)Board member Apr 20, 2011 to Jun 11, 2012⁵
Alnylam PharmaceuticalsBoard member Feb 27, 2006 to Jun 16, 2006⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Revvity Inc. RVTY28,293 shares⁷$4.3M at $152.28May 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 7, 2026Granted 1,265 shares of Revvity Inc.⁷
May 7, 2026Granted 1,015 shares of Revvity Inc.⁷
Apr 30, 2025Granted 1,338 shares of Revvity Inc.⁸
Apr 30, 2025Granted 1,074 shares of Revvity Inc.⁸
May 1, 2024Granted 1,218 shares of Revvity Inc.⁹
May 1, 2024Granted 977 shares of Revvity Inc.⁹
May 15, 2023Granted 955 shares of Revvity Inc.¹⁰
May 15, 2023Granted 783 shares of Revvity Inc.¹⁰
May 6, 2022Granted 744 shares of Revvity Inc.¹¹
May 6, 2022Granted 610 shares of Revvity Inc.¹¹
Jul 30, 2021Gift 5,000 shares of Revvity Inc.¹²
May 7, 2021Granted 709 shares of Revvity Inc.¹³
May 7, 2021Granted 604 shares of Revvity Inc.¹³
May 28, 2020Sold 7,552 shares at $100.11 of Revvity Inc.¹⁴
May 28, 2020Exercised options 4,750 shares at $42.09 of Revvity Inc.¹⁴
May 8, 2020Granted 1,081 shares of Revvity Inc.¹⁵
May 8, 2020Granted 298 shares at $92.20 of Revvity Inc.¹⁵
May 8, 2020Granted 922 shares of Revvity Inc.¹⁵
Nov 11, 2019Gift 955 shares of Revvity Inc.¹⁶
Apr 30, 2019Granted 1,043 shares of Revvity Inc.¹⁷
Apr 30, 2019Granted 785 shares of Revvity Inc.¹⁷
Feb 13, 2019Sold 5,601 shares at $93.62 of Revvity Inc.¹⁸
Feb 13, 2019Exercised options 5,601 shares at $30.51 of Revvity Inc.¹⁸
May 3, 2018Granted 1,386 shares of Revvity Inc.¹⁹
May 3, 2018Granted 1,043 shares of Revvity Inc.¹⁹

Trade performance

Date	Stock	Trade	Value	Return since	Vs S&P since	Vs S&P, 1 year
May 28, 2020	RVTY	Sale	$756.0K	+55.8%	+98.9%	−7.5%
Feb 13, 2019	RVTY	Sale	$524.4K	+65.0%	+115.7%	+20.2%

Returns are price-only (no dividends), measured from the trade date.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARObsidian Therapeutics, Inc., Board member
2
SEC EDGARRevvity Inc., Board member
3
SEC EDGARSYNLOGIC, INC., Board member
4
SEC EDGARZafgen (United States), Board member
5
SEC EDGARSciClone Pharmaceuticals (United States), Board member
6
SEC EDGARAlnylam Pharmaceuticals, Board member
7
SEC EDGARRevvity Inc. shares after the filing of May 7, 2026
8
SEC EDGARForm 4 filed May 1, 2025
9
SEC EDGARForm 4 filed May 2, 2024
10
SEC EDGARForm 4 filed May 17, 2023
11
SEC EDGARForm 4 filed May 9, 2022
12
SEC EDGARForm 4 filed Aug 2, 2021
13
SEC EDGARForm 4 filed May 10, 2021
14
SEC EDGARForm 4 filed May 29, 2020
15
SEC EDGARForm 4 filed May 12, 2020
16
SEC EDGARForm 4 filed Nov 12, 2019
17
SEC EDGARForm 4 filed May 1, 2019
18
SEC EDGARForm 4 filed Feb 14, 2019
19
SEC EDGARForm 4 filed May 4, 2018